Search tips
Search criteria 


Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2011; 6(5): e20509.
Published online 2011 May 26. doi:  10.1371/journal.pone.0020509
PMCID: PMC3102725

Deep Sequencing Reveals Novel MicroRNAs and Regulation of MicroRNA Expression during Cell Senescence

Immo A. Hansen, Editor


In cell senescence, cultured cells cease proliferating and acquire aberrant gene expression patterns. MicroRNAs (miRNAs) modulate gene expression through translational repression or mRNA degradation and have been implicated in senescence. We used deep sequencing to carry out a comprehensive survey of miRNA expression and involvement in cell senescence. Informatic analysis of small RNA sequence datasets from young and senescent IMR90 human fibroblasts identifies many miRNAs that are regulated (either up or down) with cell senescence. Comparison with mRNA expression profiles reveals potential mRNA targets of these senescence-regulated miRNAs. The target mRNAs are enriched for genes involved in biological processes associated with cell senescence. This result greatly extends existing information on the role of miRNAs in cell senescence and is consistent with miRNAs having a causal role in the process.


The accumulation of senescent cells, and their prolonged activity, disturbs the microenvironment of aging tissues, thereby compromising tissue function and contributing to age-related pathologies [1][3]. Hence there is great interest in determining the mechanisms by which senescence contributes to the aging process. Cell senescence, usually accepted as a manifestation of aging at the cellular level, occurs when cultured cells cease to proliferate, remaining viable and metabolically active but undergoing profound changes in gene expression and morphology [1], [4], [5]. Various triggers such as telomere uncapping, DNA damage, and oncogene activation can evoke senescence; such triggers can engage several mechanisms ranging from cell cycle arrest to activation of tumor suppressors. However, all senescing cells undergo profound changes in gene expression [6], [7]. Comprehensive gene expression profiling has identified genes in cell cycle, insulin growth factor, interferon, MAP kinase and oxidative stress pathways as consistently dysregulated during cell senescence [8]. Altered gene expression gives rise to the senescent phenotype, and is well established as part of the mechanisms and pathways that activate the senescence program in cells [7]. However, the factors responsible for the alterations of gene expression during senescence remain elusive.

MicroRNAs (miRNAs) are key modulators of gene expression in various biological and pathological processes [9], [10]. These RNAs, ~22 nucleotides in size, act as sequence guides that direct Argonaute protein complexes to mRNAs, where they decrease protein synthesis through translational repression or mRNA degradation [11], [12] and thereby influence many basic cellular processes [13], [14] and diseases [15,–17]. Changes in miRNA expression levels occur in cellular senescence and organismal aging [18], [19], and have been linked to changes in levels of mRNAs that are putative targets of specific miRNAs [20][22].

To date, studies exploring the role of miRNAs in senescence have relied on microarrays to assay miRNA expression. Deep sequencing, a set of technologies that produce very large amounts of sequence data from nucleic acid specimens, is rapidly replacing microarrays as the technology of choice for quantifying and annotating miRNAs [23], [24]. Deep sequencing has superior ability to capture the scale and complexity of whole transcriptomes [25]. In particular, short read deep sequencing (e.g. Illumina, Solid) is appropriate for miRNAs because a complete miRNA can be sequenced with a single read. While array design relies on knowledge of the miRNAs being interrogated, deep sequencing allows discovery of novel miRNAs. Furthermore, microarray methods lack the dynamic range to detect and quantify low abundance transcripts, but deep sequencing can identify miRNAs that are expressed at levels below the threshold of detection by microarrays. In addition, deep sequencing eliminates background problems that result from cross-hybridization in microarrays, thus facilitating interpretation of the signal and obviating the non-linear data manipulation steps required by microarrays. Therefore, the application of deep sequencing to miRNA studies has the potential to discover novel miRNAs and to detect expression of rare but functionally significant miRNAs. Deep sequencing has not previously been applied to analysis of miRNA expression in cell senescence. In this study, we conducted a deep characterization of miRNA expression in young and senescent IMR90 human fibroblasts, and predicted biological processes possibly regulated by changes in miRNA expression during senescence.


Deep sequencing of miRNAs from young and senescent fibroblasts and analysis with miRDeep2

To investigate miRNA expression during cell senescence, we used Illumina sequencing to generate and analyze 11,382,713 and 9,082,893 raw sequencing reads of small RNAs isolated from young and senescent IMR90 human lung fibroblasts, respectively. The reads were mapped to the human genome (NCBI36/hg18) and analyzed by miRDeep2, an algorithm based on the miRNA biogenesis model. It aligns sequencing reads to potential hairpin structures in a manner consistent with Dicer processing, and assigns log-odds scores to measure the probability that hairpins are true miRNA precursors. The output of this analysis is a scored list of known and novel miRNAs with their expression levels. MiRDeep2 detected 452 known miRNAs that passed the relatively stringent score cut-off of 4, which provides a signal-to-noise ratio of 15.6 (Table S1). (To detect miRNAs in deep sequencing data by miRDeep2, a score cutoff corresponding to a prediction signal-to-noise ratio >10 is often used.) MiRDeep2 predicted 46 potential novel miRNAs at the same score cut-off of 4 (Table S1). Removal of loci matching other RNA genes or genomic repeats reduced this list to 20 candidate novel miRNAs (Table 1). Illustrative examples of novel miRNAs are depicted in Fig. 1. The novel miRNA in Fig. 1A maps to a conserved genomic region, and is not annotated in the ‘Non-coding RNA Genes’ and ‘sno/miRNA’ UCSC tracks. The novel miRNA in Fig. 1B is not conserved, and is derived from an intron of the RAB40B gene. In both novel miRNAs, many more sequencing reads map to the senescent than to the young sample, indicating an induction by senescence.

Figure 1
Examples of novel miRNAs discovered by deep sequencing of IMR90 fibroblasts.
Table 1
Novel miRNAs predicted by miRDeep2 in IMR90 fibroblast data sets.

Differentially regulated known miRNAs in young and senescent fibroblasts

To test for differential miRNA expression between young and senescent fibroblasts, we used expression values generated by miRDeep2 as input for the Bioconductor DESeq package [26]. DESeq uses a negative binomial distribution model to test for differential expression in deep sequencing datasets. 141 miRNAs were induced by senescence and 131 were repressed (Table S2). Many of these have previously been identified as senescence-regulated in microarray studies [20], [27], [28], with some differences that may reflect differences in cell types and senescence models. However the results include many miRNAs not previously identified as senescence-associated: for example, mir-432 is highly induced by senescence (Fig. 2A), mir-145 is repressed (Fig. 2B), and others are depicted in Fig. 3.

Figure 2
Examples of known miRNAs that are regulated in IMR90 senescence, showing sequence depth.
Figure 3
miRNAs differentially regulated in IMR90 senescence.

Potential target genes regulated by senescence-induced miRNA expression changes

An individual miRNA may regulate hundreds of mRNAs; this ability to modulate gene expression gives miRNAs considerable influence on physiology and pathology. We computationally identified mRNA targets of miRNAs using the prediction algorithm TargetScan in ExprTargetDB [29], and identified mRNA expression patterns correlated with miRNA expression changes (see materials and methods for details of the steps used in matching miRNA and mRNA expression data). We used affy and limma Bioconductor packages to generate senescence-associated gene expression profiles from Affymetrix and two-color microarray raw data files of young and senescent IMR90 and MRC5 fibroblasts obtained from the GEO repositories GSE19018 and GSE15919, respectively. The differentially expressed genes were separated into upregulated and downregulated genes. We first matched the in silico predicted miRNA target genes to the mRNA expression obtained from the Affymetrix microarray study of IMR90 fibroblasts. These comparisons revealed 386 genes potentially downregulated by senescence-induced miRNA overexpression (Table S3), and 131 genes potentially upregulated by senescence-induced miRNA underexpression (Table S4). We then used a three-way Venn diagram to match the in silico predicted miRNA target genes to the mRNA expression obtained from the Affymetrix microarray study of IMR90 fibroblasts and the mRNA expression obtained from the two-color microarray study of MRC5 fibroblasts. This comparison revealed 143 genes potentially downregulated by senescence-induced miRNA overexpression in both types of fibroblasts (Table S5), and 36 genes potentially upregulated by senescence-induced miRNA underexpression (Table S6).

Biological processes regulated by miRNA changes during senescence

To functionally annotate the genes identified as potentially regulated by miRNAs during senescence, we used DAVID and Gene Ontology. DAVID Functional Annotation Clustering feature identifies GO terms associated with genes, and then clusters the most relevant GO terms into smaller and biologically meaningful groups. This functional annotation reveals the biological processes targeted by miRNA expression changes during senescence. Genes repressed by senescence-upregulated miRNAs produced five clusters that have enrichment scores higher than 1.3 (Table 2). Terms related to positive regulation of cell proliferation are by far the most highly represented and enriched. Other enriched biological processes suppressed by miRNA upregulation during senescence include regulation of cellular metabolic processes, nitrogen compound metabolic processes, lung development, and cell differentiation. The KEGG pathway ‘actin cytoskeleton’ was also significantly enriched (Figure S1), suggesting that miRNAs regulate cytoskeletal structure changes that give rise to the enlarged and flattened cell morphology characteristic of the senescence phenotype. Targets of miRNAs downregulated by senescence were also organized into five significant annotation clusters (Table 3), including positive regulation of cell adhesion, negative regulation of apoptosis, and cell cycle arrest. Inhibition of proliferation and resistance to apoptosis are hallmarks of senescence [5], [30], and inhibition of biosynthetic pathways may influence the cessation of growth during senescence. Conversely, stimulation of protein metabolism and modification are consistent with evidence that anabolic processes are enhanced during cellular senescence [31]. Functional annotation of genes identified as potentially regulated by miRNAs during senescence in two types of fibroblasts, IMR90 and MRC5, revealed clusters very similar to the ones obtained from the annotation of genes identified in IMR90 fibroblasts only (Table 4). Notably, senescence-induced changes in miRNA levels seem to be associated with suppression of cell proliferation and cellular metabolic processes and stimulation of cell adhesion in two types of fibroblasts, IMR90 and MRC5.

Table 2
Functional annotation clusters of enriched GO biological processes predicted to be suppressed by miRNA upregulation in senescent IMR90 fibroblasts.
Table 3
Functional annotation clusters of enriched GO biological processes predicted to be stimulated by miRNA downregulation in senescent IMR90 fibroblasts.
Table 4
Functional annotation clusters of enriched GO biological processes predicted to be regulated by miRNA changes in senescent IMR90 and MRC5 fibroblasts.

To identify miRNAs that regulate the biological processes highlighted in the annotation clusters, genes associated with all GO terms within each annotation cluster were pooled and used to perform target-centric queries with the ExprTarget integrative prediction algorithm, specifying a score cutoff of 1. A gene list pooled from all GO terms within a given annotation cluster is much more comprehensive than genes selected from individual GO terms. MiRNAs with significant ExprTarget prediction scores (Tables 2 and and3)3) were considered to be key regulators of the biological processes that were altered during senescence.


To further extend understanding of the role of miRNAs in cell senescence, we used deep sequencing to interrogate the miRNA transcriptomes of young and senescent IMR90 fibroblasts. Even though microarrays have been used to profile miRNA expression in senescence [27], [32][34], the microarray technology suffers from limitations in sensitivity and specificity [35][37]. Deep sequencing technology overcomes the disadvantages of microarrays and generates millions of small RNA sequence reads, to measure absolute abundance and to discover novel microRNAs that have evaded previous discovery efforts. MiRDeep2 analysis of the sequencing reads detected 141 known miRNAs that were induced by senescence and 131 that were repressed, and discovered 20 novel miRNAs. Some of the novel miRNAs are differentially expressed between young and senescent fibroblasts, while still showing the characteristic pattern of higher expression of the mature miRNA over the star and loop sequences. These novel sequences were missed by traditional analyses because they tend to be expressed at low levels and they are located within unannotated regions of the genome. The low expression levels of novel miRNAs are effectively detected because of the high sensitivity of deep sequencing; low expression of novel miRNAs has been observed in other studies, suggesting that the more abundant miRNAs have largely already been discovered [38]. The targets and functions of the novel miRNAs remain to be investigated.

Among the known miRNAs detected in our study, members of the highly conserved let-7 family (let-7a, let-7f, let-7e, let-7i and let-7g) were the most abundant, with read counts up to 1.7 million and highly significant miRDeep2 detection scores. We found that senescence increased let-7 expression, as previously observed in microarray miRNA profiling studies [27]. Let-7 is among several miRNAs currently considered as tumor suppressors [39], [40], which is consistent with the view that senescence evolved as a tumor-suppressive mechanism to mitigate the hazard that cancer poses to longevity [5], [40]. Expression of let-7 is abnormal in 9 cancer types [41], [42]. Let-7 miRNA overexpression was shown to be associated with senescence in fibroids [43] and in skeletal muscle of aged humans, and was proposed to contribute to decreased muscle cell renewal and regeneration [44]. Taken together, these findings suggest that let-7 miRNAs play a key role in the control of cell senescence.

Members of the miR-449 family were among the most highly induced miRNAs in senescent fibroblasts. Consistent with a possible role of this miR-449 induction in cell cycle arrest during senescence, miR-449 has been shown to inhibit cell cycle progression at G1 phase by targeting CDK6 and CDC25A, which are pivotal to G1/S-phase transition [45]. Also, miR-499 was found to be significantly upregulated in senescent human mesenchymal stem cells, with the potential to regulate all four of the senescence induction types namely, telomere attrition, oxidative stress, oncogene expression and DNA damage signaling [20]. Among the miRNAs we found to be downregulated by senescence is the miR-17-92 cluster, which is a polycistron encoding 6 mature miRNAs (miR-17, -20a, 18a, -19a, -19b-1 and -92a-1). The expression of all 6 members was decreased in senescent cells with a substantial fold change (8.0, 7.8, 6.4, 10.8, 11.1, and 4.1, respectively). MiR-17-92 is overexpressed in human cancers, and promotes tumorigenesis mainly by inhibiting oncogene-induced senescence [46], [47]. Given the anti-senescence activity of miR-17-92, our finding that all miR-17-92 members are sharply repressed with senescence suggests that its very low levels may initiate and/or sustain the senescence program. Furthermore, miR-19b was found to be downregulated in several human replicative and organismal aging models [19], and has been identified as an oncogene that activates the AKT/mTOR pathway, which modulates organismal life spans [48].

miRNA microarray studies have reported four upregulated miRNAs (miR-152, -410, -431, and -493) and four downregulated miRNAs (miR-15a, -20a, -25, and -155) in both replicative and stress-induced senescence [28]. Decreased expression of one of these, miR-155, was observed in senescent BJ fibroblasts, aged primary human WI-38 fibroblasts, and peripheral blood mononuclear cells from older individuals [49][51]. In our study, all of these eight miRNAs were regulated in the same way. Another study reported twelve miRNAs as senescence regulators [20]. Four of twelve reported miRNAs (miR-217, -34a, -369-5p, and -20a) were regulated in the same way in our study; absence of the others in our study may reflect differences in cell types and senescence models. Furthermore, miR-217 has been reported to play a role in endothelial senescence and is implicated in the pathogenesis of atherosclerosis [52]. The expression of miR-217 increases in aged endothelial cells and promotes senescence through inhibition of SirT1, which is known to promote longevity and mediates the beneficial effects of calorie restriction.

Our study identified many miRNAs that are reported here for the first time as differentially regulated by senescence, adding to the increasing evidence for miRNA regulation of the senescent program. Mir-432 is highly induced by senescence in our data as illustrated in Fig. 2A, but was never reported in previous cell senescence microarray studies. It is mentioned in the literature only as abundant in the earliest stage of fetal development [53], and has a putative binding site in the 3′ UTR of some endothelial cell-restricted genes [54]. Other miRNAs found in our study to be affected during senescence (Fig. 3), but not reported in previous senescence studies, include miR-1246, miR-584 and miR-323, which are implicated in certain cancers [55][57]. Further investigation of these miRNAs may shed new light on the roles and mechanisms of miRNAs in cellular senescence.

To improve the identification of target genes of the miRNAs that changed expression during senescence, we adopted an approach based on co-analysis of changes in both miRNA and mRNA expressions. The mRNA transcripts that were detected by microarrays as differentially expressed during senescence, and simultaneously predicted in silico as targets of differentially expressed miRNAs, were considered as potential target genes regulated by senescence-induced miRNA changes. Matching the in silico predicted target genes with the differentially regulated mRNA transcripts derived from microarrays may minimize the false positives and negatives obtained from in silico prediction. In total, 386 genes were predicted to be the targets of up-regulated miRNAs in senescent cells, while 131 genes were predicted as targets of down-regulated miRNAs (Tables S3 and S4). We also included another fibroblast type, MRC5, in the matching analysis. We found 143 genes potentially downregulated by senescence-induced miRNA overexpression in both types of fibroblasts, IMR90 and MRC5, and 36 genes potentially upregulated by senescence-induced miRNA underexpression (Tables S5 and S6). To establish the impact of these miRNA targets on senescence, we used functional annotation to identify the most relevant and meaningful biological processes and pathways associated with these potential target genes. Terms related to positive regulation of cell proliferation are by far the most highly represented and enriched among the target genes suppressed by miRNA upregulation during senescence. This is consistent with a pivotal role for miRNAs in senescence regulation, since inhibition of proliferation-promoting genes is the hallmark of senescence [5]. In parallel to the inhibition of cell proliferation during senescence, we found that miRNAs tend to promote negative regulation of apoptosis; terms such as ‘negative regulation of apoptosis’ and ‘negative regulation of programmed cell death’ were significantly enriched among the target genes stimulated by miRNA downregulation during senescence. The cell commitment to senescence instead of apoptosis is pathologically relevant because, while apoptosis eliminates damaged or stressed cells, senescence arrests their growth and allows damaged cells to persist and acquire abnormalities that alter tissue microenvironment and promote aging and cancer. Our data suggests that miRNAs may sway the cellular decision to commit to senescence instead of apoptosis. Senescent fibroblasts are known to acquire resistance to apoptotic stimuli [30], however, it remains unclear what makes a cell undergo senescence or apoptosis [5]. The miRNAs found here to be potential regulators of apoptosis resistance in senescent cells could be used to investigate the mechanisms responsible for committing cells to senescence instead of apoptosis.

Other enriched biological processes suppressed by miRNA upregulation during senescence include positive regulation of cellular metabolic and biosynthetic processes, indicating an inhibition of biosynthetic pathways, which may reflect the cessation of growth during senescence. However, GO terms related to protein metabolic processes and biopolymer modification were significantly enriched among the target genes stimulated by miRNA downregulation during senescence. The stimulation of protein metabolism and biopolymer modification is consistent with evidence that anabolic processes are enhanced during cellular senescence [31] and could be part of metabolic alterations responsible for the increase in cell volume and mass resulting in the enlarged and flattened cell morphology that is typical of senescence. Furthermore, the KEGG pathway ‘actin cytoskeleton’, which is important for cell morphology, was also significantly enriched (Figure S1); its dysregulation may be involved in rearranging cytoskeletal structures to give rise to the flattened cell morphology. We also found that terms related to positive regulation of cell adhesion were significantly enriched among the target genes stimulated by miRNA downregulation during senescence. Since the capability of cells to adhere to each other and to the extracellular matrix is linked to cytoskeleton organization and cellular shape, the changes in cell adhesion regulation may contribute to the morphological changes induced by senescence. In support of our result, a previous functional study of senescence-associated miRNA targets showed enrichment in pathways involved in cytoskeletal remodeling [20]. Thus, miRNAs may regulate the morphological changes characteristic of the senescence phenotype.

In conclusion, our deep sequencing study has identified many known miRNAs that are differentially regulated with IMR90 cell senescence, and a number of novel miRNAs. Our results included known miRNAs that have not been previously reported as differentially regulated by senescence in microarray profiling studies, thus adding to the increasing evidence for miRNA contribution to senescence. Functional analysis of mRNA transcripts targeted by senescence-regulated miRNAs indicates that miRNAs may be key contributors to the cellular changes that make up the senescence phenotype. Hence, our findings could be used to generate new hypotheses to be tested in follow-up studies designed to further elucidate the role of miRNAs in senescence.

Materials and Methods

Cell culture

IMR90 fetal lung fibroblasts were purchased from ATCC (CCL-186) and maintained as described [58]. Briefly, cells were grown in DMEM supplemented with 10% FBS, and maintained at 37°C in 5% CO2. Cells were serially passaged and were considered senescent when they stopped dividing for 2 weeks. In this study “young” IMR90 cells are cells grown for less than 14 passagings; senescent cells were passaged more than 34 times, and had ceased further growth.

RNA extraction and small RNA library construction

Total RNA, including small RNAs, was extracted from young and senescent IMR90 cells with the QIAGEN miRNeasy Mini Kit. Integrity of total RNA was checked with an Agilent 2100 Bioanalyzer. A total of 10 µg of small-RNA-enriched total RNA was electrophoresed on an 18% denaturing polyacrylamide gel with NEB miRNA markers, the gel stained with SYBR Gold, and the region corresponding to the 18–30 nucleotide bands in the marker lane was excised. Small RNA was eluted from the gel fragment and purified by standard methods. Illumina libraries were constructed from RNA specimens using the Illumina Small RNA Library kit, following the manufacturer's protocol. Briefly, 5′ and 3′ adapters were ligated to gel-purified small RNA in two separate steps, each followed by acrylamide gel purification. The ligation products were used for cDNA synthesis, followed by acrylamide gel purification and a final step of PCR amplification to generate libraries. One µl of each library was loaded on an Agilent Technologies 2100 Bioanalyzer to check size, purity, and concentration. Libraries were sequenced on an Illumina GAII instrument to generate 36 base reads. Sequencing data was processed with the Illumina pipeline v1.3.2. The MIAME-compliant sequencing data has been deposited in Gene Expression Omnibus (GEO) with accession number GSE27404.

MiRDeep2 analysis of sequencing reads

Raw small RNA sequencing data were analyzed with miRDeep2 [59], a probabilistic algorithm based on the miRNA biogenesis model and designed to detect miRNAs from deep sequencing reads. Briefly, miRDeep2 pre-processed raw sequencing reads by removing the 3′ adapter sequence and discarding reads shorter than 18 nucleotides, before aligning reads to the human genome (NCBI36/hg18). Only reads that mapped perfectly to the genome five or less times were used for miRNA detection, since human miRNAs usually map to few genomic locations. MiRDeep2 estimates expression levels of known miRNAs, and also identifies novel miRNAs. The situation with deep sequencing is quite different from a microarray experiment, where only known miRNAs appear as features: any genomic sequence may potentially appear in the sequence dataset, and the informatics task is to determine which of these are miRNAs. Small RNAs identified by short read sequencing are derived from longer RNAs, and may or may not be true miRNAs. The miRDeep2 algorithm is based on the miRNA biogenesis model; it aligns reads to potential hairpin structures in a manner consistent with Dicer processing and assigns scores that measure the probability that hairpins are true miRNA precursors. MiRDeep2 then uses known characteristics of miRNA biogenesis to score the likelihood that the reads are derived from true miRNAs: a small RNA derived from the 5′ end of a predicted precursor is likely to be a miRNA if it is highly abundant relative to small RNAs derived from loop and star regions of the precursor, and less likely to be a true miRNA if it is present in similar proportions to the loop and star. The miRDeep2 algorithm uses this principle to produce a log-odds score that a small RNA is a true miRNA; it outputs a scored list of known and novel miRNAs as well as their expression levels.

Statistical analysis of differential miRNA expression

In addition to identifying mature miRNAs in deep sequenced small RNA samples, miRDeep2 also generates expression values for the detected miRNAs. To test for differential miRNA expression between young and senescent fibroblasts, expression data for known miRNAs produced by miRDeep2 was used as input for the Bioconductor DESeq package [26]. DESeq uses a negative binomial distribution model to test for differential expression in deep sequencing datasets. The list of differentially expressed miRNAs produced by DESeq was further filtered to remove miRNAs with less than 10 reads in both samples, and fold change between samples less than 1.5.

Potential target genes regulated by senescence-induced miRNA expression changes

To identify mRNA expression patterns associated with miRNA expression changes, we matched miRNA and mRNA expression data, and considered a miRNA to be regulatory only if expression levels of miRNA and its known mRNA targets are anti-correlated. This analysis was carried out in 3 steps:

Step 1. In silico prediction of genes targeted by miRNAs displaying differential expression in senescent fibroblasts

To functionally characterize the differentially expressed miRNAs, we identified their target transcripts, using ExprTargetDB [29], which uses a public database of human miRNA targets, to yield a comprehensive catalogue of miRNA targets. We queried ExprTargetDB with the 272 miRNAs displaying differential expression in senescent IMR90 fibroblasts (listed in Table S4) by selecting TargetScan as prediction algorithm and specifying a p-value cutoff of 0.05. Since we expect an inverse relationship between mRNA and miRNA expression, we predicted the transcripts targeted by upregulated miRNAs separately from the ones targeted by downregulated miRNAs. This analysis yielded two lists of upregulated and downregulated mRNA transcripts that are potentially regulated by senescence-induced changes in miRNA expression.

Step 2. Gene expression profiling of senescence

MIAME-compliant raw data of mRNA microarrays (Affymetrix Human Genome U133 Plus 2.0; containing 39,000 genes) were obtained from the Gene Expression Omnibus repository (accession number GSE19018). The CEL files GSM470491, GSM470492, and GSM470493 were from young and GSM470494, GSM470495, and GSM470496 from senescent IMR90 human fibroblasts. We used Robust Multichip Average (RMA) algorithms of the Bioconductor R package affy [60], [61] to pre-process the raw CEL files and normalize the probe expression levels. Normalized data were tested for differential expression with the SAM module in the Bioconductor siggenes package (; [62]) using a cut-off of 15% FDR. A second set of MIAME-compliant raw data of mRNA two-color microarrays (NCI/ATC Hs-OperonV2; featuring 21,329 probes) was obtained from the Gene Expression Omnibus repository (accession number GSE15919; [63]. This set contains 6 arrays, which were hybridized with RNAs from MRC5 fibroblasts at population doubling 63 (senescent) and from MRC5 fibroblasts at population doubling 28 (young). The six arrays correspond to 3 biological replicates, each with a dye-swap technical replicate. The arrays were analyzed with Bioconductor limma package [64], [65] to identify genes differentially expressed in senescent MRC5 fibroblasts. Limma uses linear models to analyze microarray experiments. Briefly, the intensity data were imported with a filter so that any spot with a flag of −50 or less gets zero weight. The flag function assigns a zero to a normal spot and increasingly negative values for increasingly problematic spots. We implemented the ‘normexp’ method with an offset of 50 to correct the background and a loess normalization method (‘printtiploess’) to normalize within arrays. Differentially expressed genes were obtained by fitting a linear model to the normalized data followed by computing empirical Bayes statistics. The dye-effect was included in the model to adjust for any probe-specific dye effects. The p-values were adjusted for multiple testing using Benjamini and Hochberg's method to control the false discovery rate (FDR). Genes with FDR below 0.05 were selected as differentially expressed. The differentially expressed genes were separated into 2 lists of upregulated and downregulated genes, which we used in the next step of the analysis.

Step 3. Identification of potential target mRNAs by matching the in silico predicted miRNA target genes to experimentally determined microarray mRNA expression

We identified potential gene targets of the upregulated miRNAs by comparison of their predicted target mRNAs (from step 1) with downregulated mRNAs derived from the senescent IMR90 or MRC5 microarray studies (from step 2). Similarly, predicted target mRNAs for downregulated miRNAs were compared to upregulated mRNAs derived from the microarray study. These genes resulting from matching analysis of computational prediction of miRNA target genes and differentially expressed genes in microarray senescence experiments were considered as genes potentially regulated by senescence-induced miRNA changes, and were chosen for downstream functional and pathway analyses.

Functional annotation of miRNA targets

To characterize biological processes affected by senescence-induced miRNA expression changes, we used Gene Ontology (GO) and the functional annotation clustering feature of DAVID [66], [67] to functionally annotate genes that are potentially regulated by miRNAs during senescence. We also used the clustering analysis to analyze the significance of KEGG pathways in our data. The functional annotation clustering tool measures the similarities among GO terms based on the extent of their associated genes and assembles the similar and redundant GO terms into annotation clusters. Each GO term in a cluster is assigned a Fisher Exact p-value representing the degree of enrichment of the GO term in the input gene list. Each cluster is assigned an enrichment score to rank its biological significance. This enrichment score is derived from the geometric mean (in -log scale) of member's p-values. Thus, a biologically significant cluster (high enrichment score) is generated only when most of its GO term members have significant enrichment values (low Fisher Exact p-values). The resulting clusters were further curated to keep only GO terms with p-values <0.05.

Identification of miRNAs associated with biological processes altered by senescence

To identify miRNAs that are key regulators of the biological processes included in the annotation clusters, the GO terms within each annotation cluster were subjected to computational analysis. Genes associated with all GO terms within each annotation cluster were retrieved using DAVID's genes link (G) provided for each cluster. This function pools all genes from different GO terms within a selected cluster into one list. Genes pooled from each annotation cluster were submitted to the public database of human miRNA targets (ExprTargetDB) to perform target-centric queries using the ExprTarget integrative prediction algorithm. MiRNAs resulting from this analysis were further filtered to keep only miRNAs with significant prediction scores. These miRNAs are predicted to be key regulators of the biological processes that are altered during senescence.

Supporting Information

Figure S1

Significantly overrepresented KEGG ‘actin cytoskeleton’ pathway associated with miRNAs overexpressed during senescence. KEGG pathway mapping was performed using DAVID. The genes marked with an oval represent the targets of the senescence-induced miRNA overexpression.


Table S1

Survey of miRDeep2 performance showing number of novel and known miRNAs and value of signal-to-noise ratio under different score cut-offs ranging from 10 to 1.


Table S2

MiRNAs differentially expressed in cell senescence.


Table S3

Potential target genes downregulated by senescence-induced miRNA overexpression in IMR90 fibroblasts.


Table S4

Potential target genes upregulated by senescence-induced miRNA underexpression in IMR90 fibroblasts.


Table S5

Potential target genes downregulated by senescence-induced miRNA overexpression in both types of fibroblasts, IMR90 and MRC5.


Table S6

Potential target genes upregulated by senescence-induced miRNA underexpression in both types of fibroblasts, IMR90 and MRC5.



We thank Bruno Santos for help with Informatics.


Competing Interests: The authors have declared that no competing interests exist.

Funding: This work was supported by NIH grants ES016581, CA115768, DK080428 (DM) and HL084474 (DB). JD was a Scholar of the California Institute of Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Jeyapalan JC, Ferreira M, Sedivy JM, Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev. 2007;128:36–44. [PubMed]
2. Davalos AR, Coppe JP, Campisi J, Desprez PY. Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev. 2010;29:273–283. [PMC free article] [PubMed]
3. Campisi J. The biology of replicative senescence. Eur J Cancer. 1997;33:703–709. [PubMed]
4. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995;92:9363–9367. [PubMed]
5. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8:729–740. [PubMed]
6. Gruber HE, Hoelscher GL, Ingram JA, Zinchenko N, Hanley EN., Jr Senescent vs. non-senescent cells in the human annulus in vivo: cell harvest with laser capture microdissection and gene expression studies with microarray analysis. BMC Biotechnol. 2010;10:5. [PMC free article] [PubMed]
7. Muller M. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal. 2009;11:59–98. [PubMed]
8. Fridman AL, Tainsky MA. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene. 2008;27:5975–5987. [PubMed]
9. Grosshans H, Filipowicz W. Molecular biology: the expanding world of small RNAs. Nature. 2008;451:414–416. [PubMed]
10. Silahtaroglu A, Stenvang J. MicroRNAs, epigenetics and disease. Essays Biochem. 2010;48:165–185. [PubMed]
11. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351–379. [PubMed]
12. Thomas M, Lieberman J, Lal A. Desperately seeking microRNA targets. Nat Struct Mol Biol. 2010;17:1169–1174. [PubMed]
13. Ivey KN, Srivastava D. MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem Cell. 2010;7:36–41. [PubMed]
14. Townley-Tilson WH, Callis TE, Wang D. MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease. Int J Biochem Cell Biol. 2010;42:1252–1255. [PMC free article] [PubMed]
15. da Costa Martins PA, Leptidis S, Salic K, De Windt LJ. MicroRNA regulation in cardiovascular disease. Curr Drug Targets. 2010;11:900–906. [PubMed]
16. Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol. 2011;223:102–115. [PMC free article] [PubMed]
17. Saugstad JA. MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration. J Cereb Blood Flow Metab. 2010;30:1564–1576. [PMC free article] [PubMed]
18. Grillari J, Grillari-Voglauer R. Novel modulators of senescence, aging, and longevity: Small non-coding RNAs enter the stage. Exp Gerontol. 2010;45:302–311. [PubMed]
19. Hackl M, Brunner S, Fortschegger K, Schreiner C, Micutkova L, et al. miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging. Aging Cell. 2010;9:291–296. [PMC free article] [PubMed]
20. Lafferty-Whyte K, Cairney CJ, Jamieson NB, Oien KA, Keith WN. Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms. Biochim Biophys Acta. 2009;1792:341–352. [PubMed]
21. He L, He X, Lim LP, de Stanchina E, Xuan Z, et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007;447:1130–1134. [PubMed]
22. Maes OC, Sarojini H, Wang E. Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts. J Cell Physiol. 2009;221:109–119. [PubMed]
23. McCormick KP, Willmann MR, Meyers BC. Experimental design, preprocessing, normalization and differential expression analysis of small RNA sequencing experiments. Silence. 2011;2:2. [PMC free article] [PubMed]
24. Wittmann J, Jack HM. New surprises from the deep--the family of small regulatory RNAs increases. ScientificWorldJournal. 2010;10:1239–1243. [PubMed]
25. Costa V, Angelini C, De Feis I, Ciccodicola A. Uncovering the complexity of transcriptomes with RNA-Seq. J Biomed Biotechnol. 2010;2010 [PMC free article] [PubMed]
26. Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11:R106. [PMC free article] [PubMed]
27. Marasa BS, Srikantan S, Martindale JL, Kim MM, Lee EK, et al. MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence. Aging (Albany NY) 2010;2:333–343. [PMC free article] [PubMed]
28. Wang Y, Scheiber MN, Neumann C, Calin GA, Zhou D. Int J Radiat Oncol Biol Phys; 2010. MicroRNA Regulation of Ionizing Radiation-Induced Premature Senescence. [PMC free article] [PubMed]
29. Gamazon ER, Im HK, Duan S, Lussier YA, Cox NJ, et al. Exprtarget: an integrative approach to predicting human microRNA targets. PLoS One. 2010;5:e13534. [PMC free article] [PubMed]
30. Ryu SJ, Park SC. Targeting major vault protein in senescence-associated apoptosis resistance. Expert Opin Ther Targets. 2009;13:479–484. [PubMed]
31. Kim YM, Seo YH, Park CB, Yoon SH, Yoon G. Roles of GSK3 in metabolic shift toward abnormal anabolism in cell senescence. Ann N Y Acad Sci. 2010;1201:65–71. [PubMed]
32. Martinez I, Cazalla D, Almstead LL, Steitz JA, DiMaio D. miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc Natl Acad Sci U S A. 2011;108:522–527. [PubMed]
33. Rizzo M, Mariani L, Pitto L, Rainaldi G, Simili M. miR-20a and miR-290, multi-faceted players with a role in tumourigenesis and senescence. J Cell Mol Med. 2010;14:2633–2640. [PubMed]
34. Ito T, Yagi S, Yamakuchi M. MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun. 2010;398:735–740. [PubMed]
35. Creighton CJ, Reid JG, Gunaratne PH. Expression profiling of microRNAs by deep sequencing. Brief Bioinform. 2009;10:490–497. [PMC free article] [PubMed]
36. Ansorge WJ. Next-generation DNA sequencing techniques. N Biotechnol. 2009;25:195–203. [PubMed]
37. Hurd PJ, Nelson CJ. Advantages of next-generation sequencing versus the microarray in epigenetic research. Brief Funct Genomic Proteomic. 2009;8:174–183. [PubMed]
38. Meiri E, Levy A, Benjamin H, Ben-David M, Cohen L, et al. Discovery of microRNAs and other small RNAs in solid tumors. Nucleic Acids Res. 2010;38:6234–6246. [PMC free article] [PubMed]
39. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302:1–12. [PubMed]
40. Ortholan C, Puissegur MP, Ilie M, Barbry P, Mari B, et al. MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets. Curr Med Chem. 2009;16:1047–1061. [PubMed]
41. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer. 2010;17:F19–36. [PubMed]
42. Jiang Q, Wang Y, Hao Y, Juan L, Teng M, et al. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res. 2009;37:D98–104. [PMC free article] [PubMed]
43. Laser J, Lee P, Wei JJ. Cellular senescence in usual type uterine leiomyoma. Fertil Steril. 2010;93:2020–2026. [PubMed]
44. Drummond MJ, McCarthy JJ, Sinha M, Spratt HM, Volpi E, et al. Physiol Genomics; 2010. Aging and MicroRNA Expression in Human Skeletal Muscle: A Microarray and Bioinformatics Analysis. [PubMed]
45. Yang X, Feng M, Jiang X, Wu Z, Li Z, et al. miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A. Genes Dev. 2009;23:2388–2393. [PubMed]
46. Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell. 2008;133:217–222. [PMC free article] [PubMed]
47. Hong L, Lai M, Chen M, Xie C, Liao R, et al. The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. Cancer Res. 2010;70:8547–8557. [PMC free article] [PubMed]
48. Grillari J, Hackl M, Grillari-Voglauer R. miR-17-92 cluster: ups and downs in cancer and aging. Biogerontology. 2010;11:501–506. [PMC free article] [PubMed]
49. Bonifacio LN, Jarstfer MB. MiRNA profile associated with replicative senescence, extended cell culture, and ectopic telomerase expression in human foreskin fibroblasts. PLoS One. 2010;5 [PMC free article] [PubMed]
50. Brosh R, Shalgi R, Liran A, Landan G, Korotayev K, et al. p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. Mol Syst Biol. 2008;4:229. [PMC free article] [PubMed]
51. Noren Hooten N, Abdelmohsen K, Gorospe M, Ejiogu N, Zonderman AB, et al. microRNA expression patterns reveal differential expression of target genes with age. PLoS One. 2010;5:e10724. [PMC free article] [PubMed]
52. Menghini R, Casagrande V, Cardellini M, Martelli E, Terrinoni A, et al. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation. 2009;120:1524–1532. [PubMed]
53. McDaneld TG, Smith TP, Doumit ME, Miles JR, Coutinho LL, et al. MicroRNA transcriptome profiles during swine skeletal muscle development. BMC Genomics. 2009;10:77. [PMC free article] [PubMed]
54. Bhasin M, Yuan L, Keskin DB, Otu HH, Libermann TA, et al. Bioinformatic identification and characterization of human endothelial cell-restricted genes. BMC Genomics. 2010;11:342. [PMC free article] [PubMed]
55. Witten D, Tibshirani R, Gu SG, Fire A, Lui WO. Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol. 2010;8:58. [PMC free article] [PubMed]
56. Wang XY, Wu MH, Liu F, Li Y, Li N, et al. Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells. Mol Cell Biochem. 2010;345:283–290. [PubMed]
57. Dixon-McIver A, East P, Mein CA, Cazier JB, Molloy G, et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One. 2008;3:e2141. [PMC free article] [PubMed]
58. Atamna H, Paler-Martinez A, Ames BN. N-t-butyl hydroxylamine, a hydrolysis product of alpha-phenyl-N-t-butyl nitrone, is more potent in delaying senescence in human lung fibroblasts. J Biol Chem. 2000;275:6741–6748. [PubMed]
59. Friedlander MR, Chen W, Adamidi C, Maaskola J, Einspanier R, et al. Discovering microRNAs from deep sequencing data using miRDeep. Nat Biotechnol. 2008;26:407–415. [PubMed]
60. Gautier L, Cope L, Bolstad BM, Irizarry RA. affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20:307–315. [PubMed]
61. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185–193. [PubMed]
62. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98:5116–5121. [PubMed]
63. Binet R, Ythier D, Robles AI, Collado M, Larrieu D, et al. WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer Res. 2009;69:9183–9191. [PubMed]
64. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3. [PubMed]
65. Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, et al. A comparison of background correction methods for two-colour microarrays. Bioinformatics. 2007;23:2700–2707. [PubMed]
66. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57. [PubMed]
67. Dennis G, Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4:P3. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science